Overview

MoviPrep® Versus GoLYTELY® Bowel Preparation in Hospitalized Patients Undergoing Colonoscopy

Status:
Not yet recruiting
Trial end date:
2023-08-01
Target enrollment:
0
Participant gender:
All
Summary
Adequate bowel cleansing is a critical component in the care of hospitalized patients undergoing colonoscopy. However, inpatient status is a well-established risk factor for inadequate bowel preparation. However, few strategies have been rigorously shown to reduce the risk of inadequate bowel preparation. Moreover, inadequate bowel preparation is frequently related to the poor tolerability of high volumes of bowel preparation in the medically complex and comorbid hospitalized population. Low volume bowel preparations have been developed that have been shown to be noninferior compared to high volume bowel preparation with regards to adequacy of bowel preparation but with improved tolerability. However, the use of low volume bowel preparations for colonoscopies have largely been evaluated in the outpatient setting. In this study, we plan to compare rates of adequate bowel preparation and tolerability of a low volume bowel preparation, MoviPrep, compared to standard high volume bowel preparation, GoLYTELY, in hospitalized patients undergoing colonoscopy. This study promises to highlight low volume bowel preparation as a viable and better tolerated alternative to high volume bowel preparation in hospitalized patients which may ultimately decrease delays in inpatient endoscopy as well as hospital length of stay.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Yale University
Criteria
Inclusion Criteria:

1. Provision of signed and dated informed consent form

2. Stated willingness to comply with all study procedures and availability for the
duration of the study

3. Male or female, aged 18 or greater

4. Hospitalized patient scheduled to undergo colonoscopy with bowel preparation (not
including preparation with enemas alone)

5. Ability to take bowel preparation and be willing to adhere to the regimen

Exclusion Criteria:

1. Patients presenting to the hospital with ileus, toxic megacolon, evidence of
gastrointestinal obstruction

2. Receipt of bowel preparation for other reasons during their hospitalization prior to
their colonoscopy

3. Patients with prior significant gastrointestinal surgeries including colonic
resection, subtotal colectomy, abdomino-perineal resection, Hartmann's procedure or
other similar surgeries involving structure/function of small intestine or colon

4. Unable to give informed consent to the procedure

5. Known glucose-6-phosphate dehydrogenase deficiency

6. Known phenylketonuria

7. Known hypersensitivity to polyethylene glycols or ascorbic acid

8. Patients undergoing colonoscopy for foreign body removal and/or decompression

9. Pregnancy or lactating women